Cargando…

Mitochondrial malic enzyme 2 promotes breast cancer metastasis via stabilizing HIF-1α under hypoxia

OBJECTIVE: α-ketoglutarate (α-KG) is the substrate to hydroxylate collagen and hypoxia-inducible factor-1α (HIF-1α), which are important for cancer metastasis. Previous studies have shown that the upregulation of collagen prolyl 4-hydroxylase in breast cancer cells stabilizes the expression of HIF-1...

Descripción completa

Detalles Bibliográficos
Autores principales: You, Duo, Du, Danfeng, Zhao, Xueke, Li, Xinmin, Ying, Minfeng, Hu, Xun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8286887/
https://www.ncbi.nlm.nih.gov/pubmed/34321828
http://dx.doi.org/10.21147/j.issn.1000-9604.2021.03.03
_version_ 1783723806822498304
author You, Duo
Du, Danfeng
Zhao, Xueke
Li, Xinmin
Ying, Minfeng
Hu, Xun
author_facet You, Duo
Du, Danfeng
Zhao, Xueke
Li, Xinmin
Ying, Minfeng
Hu, Xun
author_sort You, Duo
collection PubMed
description OBJECTIVE: α-ketoglutarate (α-KG) is the substrate to hydroxylate collagen and hypoxia-inducible factor-1α (HIF-1α), which are important for cancer metastasis. Previous studies have shown that the upregulation of collagen prolyl 4-hydroxylase in breast cancer cells stabilizes the expression of HIF-1α by depleting α-KG levels. We hypothesized that mitochondrial malic enzyme 2 (ME2) might also affect HIF-1α expression via modulating α-KG levels in breast cancer cells. METHODS: We evaluated ME2 protein expression in 100 breast cancer patients using immunohistochemistry and correlated with clinicopathological indicators. The effect of ME2 knockout on cancer metastasis was evaluated using an orthotopic breast cancer model. The effect of ME2 knockout or knockdown on the levels of α-KG and HIF-1α proteins in breast cancer cell lines was determined both in vitro and in vivo. RESULTS: ME2 was found to be upregulated in the human breast cancerous tissues compared with the matched precancerous tissues (P<0.001). The elevated expression of ME2 was associated with a poor prognosis (P=0.019). ME2 upregulation was also related to lymph node metastasis (P=0.016), pathological staging (P=0.033), and vascular cancer embolus (P=0.014). Also, ME2 knockout significantly inhibited lung metastasisin vivo. In the tumors formed by ME2 knockout cells, the levels of α-KG were significantly increased and collagen hydroxylation level did not change significantly but HIF-1α protein expression was significantly decreased, compared to the control samples. In cell culture, cells with ME2 knockout or knockdown demonstrated significantly higher α-KG levels but significantly lower HIF-1α protein expression than control cells under hypoxia. Exogenous malate and α-KG exerted similar effect on HIF-1α in breast cancer cells to ME2 knockout or knockdown. Additionally, treatment with malate significantly decreased 4T1 breast cancer lung metastasis. ME2 expression was associated with HIF-1α levels in human breast cancer samples (P=0.008). CONCLUSIONS: Our results provide evidence that upregulation of ME2 is associated with a poor prognosis of breast cancer patients and propose a mechanistic understanding of a link between ME2 and breast cancer metastasis.
format Online
Article
Text
id pubmed-8286887
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-82868872021-07-27 Mitochondrial malic enzyme 2 promotes breast cancer metastasis via stabilizing HIF-1α under hypoxia You, Duo Du, Danfeng Zhao, Xueke Li, Xinmin Ying, Minfeng Hu, Xun Chin J Cancer Res Original Article OBJECTIVE: α-ketoglutarate (α-KG) is the substrate to hydroxylate collagen and hypoxia-inducible factor-1α (HIF-1α), which are important for cancer metastasis. Previous studies have shown that the upregulation of collagen prolyl 4-hydroxylase in breast cancer cells stabilizes the expression of HIF-1α by depleting α-KG levels. We hypothesized that mitochondrial malic enzyme 2 (ME2) might also affect HIF-1α expression via modulating α-KG levels in breast cancer cells. METHODS: We evaluated ME2 protein expression in 100 breast cancer patients using immunohistochemistry and correlated with clinicopathological indicators. The effect of ME2 knockout on cancer metastasis was evaluated using an orthotopic breast cancer model. The effect of ME2 knockout or knockdown on the levels of α-KG and HIF-1α proteins in breast cancer cell lines was determined both in vitro and in vivo. RESULTS: ME2 was found to be upregulated in the human breast cancerous tissues compared with the matched precancerous tissues (P<0.001). The elevated expression of ME2 was associated with a poor prognosis (P=0.019). ME2 upregulation was also related to lymph node metastasis (P=0.016), pathological staging (P=0.033), and vascular cancer embolus (P=0.014). Also, ME2 knockout significantly inhibited lung metastasisin vivo. In the tumors formed by ME2 knockout cells, the levels of α-KG were significantly increased and collagen hydroxylation level did not change significantly but HIF-1α protein expression was significantly decreased, compared to the control samples. In cell culture, cells with ME2 knockout or knockdown demonstrated significantly higher α-KG levels but significantly lower HIF-1α protein expression than control cells under hypoxia. Exogenous malate and α-KG exerted similar effect on HIF-1α in breast cancer cells to ME2 knockout or knockdown. Additionally, treatment with malate significantly decreased 4T1 breast cancer lung metastasis. ME2 expression was associated with HIF-1α levels in human breast cancer samples (P=0.008). CONCLUSIONS: Our results provide evidence that upregulation of ME2 is associated with a poor prognosis of breast cancer patients and propose a mechanistic understanding of a link between ME2 and breast cancer metastasis. AME Publishing Company 2021-06-30 /pmc/articles/PMC8286887/ /pubmed/34321828 http://dx.doi.org/10.21147/j.issn.1000-9604.2021.03.03 Text en Copyright ©2021Chinese Journal of Cancer Research. All rights reserved. https://creativecommons.org/licenses/by-nc-sa/4.0/This work is licensed under a Creative Commons Attribution-Non Commercial-Share Alike 4.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ (https://creativecommons.org/licenses/by-nc-sa/4.0/)
spellingShingle Original Article
You, Duo
Du, Danfeng
Zhao, Xueke
Li, Xinmin
Ying, Minfeng
Hu, Xun
Mitochondrial malic enzyme 2 promotes breast cancer metastasis via stabilizing HIF-1α under hypoxia
title Mitochondrial malic enzyme 2 promotes breast cancer metastasis via stabilizing HIF-1α under hypoxia
title_full Mitochondrial malic enzyme 2 promotes breast cancer metastasis via stabilizing HIF-1α under hypoxia
title_fullStr Mitochondrial malic enzyme 2 promotes breast cancer metastasis via stabilizing HIF-1α under hypoxia
title_full_unstemmed Mitochondrial malic enzyme 2 promotes breast cancer metastasis via stabilizing HIF-1α under hypoxia
title_short Mitochondrial malic enzyme 2 promotes breast cancer metastasis via stabilizing HIF-1α under hypoxia
title_sort mitochondrial malic enzyme 2 promotes breast cancer metastasis via stabilizing hif-1α under hypoxia
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8286887/
https://www.ncbi.nlm.nih.gov/pubmed/34321828
http://dx.doi.org/10.21147/j.issn.1000-9604.2021.03.03
work_keys_str_mv AT youduo mitochondrialmalicenzyme2promotesbreastcancermetastasisviastabilizinghif1aunderhypoxia
AT dudanfeng mitochondrialmalicenzyme2promotesbreastcancermetastasisviastabilizinghif1aunderhypoxia
AT zhaoxueke mitochondrialmalicenzyme2promotesbreastcancermetastasisviastabilizinghif1aunderhypoxia
AT lixinmin mitochondrialmalicenzyme2promotesbreastcancermetastasisviastabilizinghif1aunderhypoxia
AT yingminfeng mitochondrialmalicenzyme2promotesbreastcancermetastasisviastabilizinghif1aunderhypoxia
AT huxun mitochondrialmalicenzyme2promotesbreastcancermetastasisviastabilizinghif1aunderhypoxia